Danny C. Reeves
JUDGMENT
In accordance with the Court's Order Granting Defendant Xanodyne Pharmaceuticals, Inc.'s Motion to Dismiss and Motion for Judgment on the Pleadings in 14 Cases [MDL Record No. 1791], Order dismissing remaining Generic Defendants [MDL Record No. 1973], Memorandum Opinion and Order Regarding AAIPharma, LLC's AAIPharma, Inc.'s AAIPharma Development Services, Inc.'s, and NeoSan Pharmaceutical, Inc.'s Motion to Dismiss [MDL Record No. 2150], and Memorandum Opinion and Order Granting Defendant Eli Lilly and Company's Third Master Motion for Judgment on the Pleadings in Twelve Cases [MDL Record No. 2184], and pursuant to Rule 58 of the Federal Rules of Civil Procedure, it is hereby
ORDERED and ADJUDGED as follows:
(1) Judgment is entered in favor of Eli Lilly and Company; aaiPharma, Inc.; aaiPharma LLC; AAI Development Services, Inc.; NeoSan Pharmaceuticals Inc.; Xanodyne Pharmaceuticals, Inc.; Qualitest Pharmaceuticals, Inc.; Vintage Pharmaceuticals, Inc.; Propst
Distribution, Inc.; Brenn Distribution, Inc.; Brenn Manufacturing, Inc.; Vintage Pharmaceuticals, LLC; Generics International (US), Inc.; Generics Bidco I, LLC; Generics Bidco II, LLC; Generics International (US PARENT), Inc.; Endo Pharmaceuticals, Inc.; Endo Pharmaceuticals Holdings, Inc.; Covidien PLC; Covidien Inc.; Mallinckrodt, Inc.; Teva Biopharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals, Inc.; Mylan, Inc.; and Watson Pharmaceuticals, Inc. with respect to all claims asserted herein.
(2) This action is DISMISSED and STRICKEN from the Court's docket.
(3) This is a FINAL and APPEALABLE Judgment and there is no just cause for delay.
Signed By:
Danny C. Reeves
United States District Judge